4[CHAPTER 30
PHARMACEUTICAL
Main Notes
1 “The words ‘ Heavy metals within permissible limits’ have be conspicuously displayed on the container of purely Herbal Ayurveda, Siddha and Unani medicines to be exported. Alternatively, a Certificate that ‘ Heavy metals within permissible limits ‘ issued either by an inhouse laboratory fully equipped with appropriate equipments for testing heavy metals or by any other NABL / GLP accredited laboratory or any other approved laboratory has to be produced along with other consignment papers.”
2 Formulations of plant portions of prohibited varieties falling in heading 3003 and heading 3004 are freely exportable subject to conditions. For details, please see chapter 12
Policy Conditions1 Cough Syrup shall be permitted to be exported subject to the export sample being tested and production of Certificate of Analysis (CoA) issued by any of the following laboratories: Indian Pharmacopoeia Commission, Ghaziabad, Uttar Pradesh
CDL, Kolkata, West Bengal
CDTL, Chennai, Tamil Nadu
CDTL, Mumbai, Maharashtra
CDTL, Hyderabad, Telangana
RDTL, Chandigarh
RDTL, Guwahati, Assam
Any NABL accredited State Drugs Testing Laboratory
2 Exports of Derivatives, extracts and formulations is free, subject to the provisions of Wild Life (Protection) Act, 1972 and “CITES”
3 Exports of All wild animals, animal
articles including their products and derivatives excluding those for
which ownership certificates have been granted and also those required
for transactions for education, scientific research and management under
Wild Life (Protection) Act, 1972 including their parts and products are
Prohibited and not permitted to be exported
| Chapter
Number |
ITC-HS Codes | Description | Dashes | Export Policy | Policy Condition | Notification No | Notification Date |
| 30 | 30 | Pharmaceutical Products. | Prohibited | Export of All wild animals, animal articles including their products and derivatives excluding those for which ownership certificates have been granted and also those required for transactions for education, scientific research and management under Wild Life (Protection) Act, 1972 including their parts and products is Prohibited and not permitted to be exported | |||
| 30 | 3001 | Glands and other organs for organo-therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included. | Free | 56/2015-20 | 24.02.2022 | ||
| 30 | 300120 | Extracts of glands or other organs or of their secretions | - | ||||
| 30 | 30012010 | Liquid extracts of liver | --- | Free | |||
| 30 | 30012020 | Liver extracts, dry | --- | Free | |||
| 30 | 30012030 | Snake Venom | --- | Free | |||
| 30 | 30012090 | Other | --- | Free | However, the following items are Restricted for
exports and permitted under License: 1. Gonads and other reproductive organs of buffaloes 2. Germplasm of cattle and buffaloes |
||
| 30 | 300190 | Other | - | ||||
| 30 | 30019010 | Of human origin | --- | Free | |||
| 30 | 30019091 | Other: ---- Heparin and its salts |
--- | Free | Export of Heparin and its salts is Free wherein
export of the item produced from animal by-products allowed freely but
export to European Union allowed subject to the following conditions : (i) A ‘Shipment Clearance Certificate’ is to be issued consignment-wise by the CAPEXIL indicating details of the name and address of the exporter, address of the registered plant, IEC No. of the exporter, Plant approval number, nature of export product, quantity, invoice number and date, port of loading (name of the port) and destination; (ii) After the shipment is made, the exporter shall also provide a ‘Health Certificate’ consignment-wise to the buyer giving details of the product with HS Code, packaging, its origin, destination, vessel name, date of departure, health requirements, etc. This Health Certificate would be issued jointly by CAPEXIL and Regional Animal Quarantine Officer, Department of Animal Husbandry, Dairying and Fisheries, Ministry of Agriculture and Farmers Welfare, Government of India. |
34/2015-20 | 13.01.2017 |
| 30 | 30019099 | Other: ---- Other |
--- | Free | However, the following items are Restricted for
exports and permitted under License: 1. Gonads and other reproductive organs of buffaloes 2. Germplasm of cattle and buffaloes |
||
| 30 | 3002 | HUMAN BLOOD; ANIMAL BLOOD PREPARED FORTHERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES,TOXINS, CULTURES OF MICROORGANISMS (EXCLUDING YEASTS) AND ETHER SIMILAR PRODUCTS; CELL CULTURES, WHETHER OR NOT MODIFIED | Free | 56/2015-20 | 24.02.2022 | ||
| 30 | 300210 | Antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes | |||||
| 30 | 30021020 | Antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes | --- |
5[Free
subject NOC] [helldodold[Free]helldod] |
5[1. Any human biological
materials/samples/products which are related to activities covered under
the provision of Drugs & Cosmetics Act 1940 & Rules thereunder are free
for export subject to No objection from CDSCO. 2. Any human biological materials/samples/products NOT covered under (1) above are free for export subject to No objection from ICMR/DHR.] [helldodold[1. Export of Whole human blood plasma and all products derived from human blood except gamma globulin and human serum albumin manufactured from human placenta and human placental blood; Raw placenta; Placental blood plasma is freely allowed subject to obtaining No Objection Certificate from DGHS 2. Exports of Gamma globulin and human serum albumin manufactured from human placenta and human placental blood is free. 3. Export of Antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes and Hemoglobin blood globulins and serum globulins is free wherein Export of the item produced from animal by-products is allowed freely but export to European Union allowed subject to the following conditions : (i) A ‘Shipment Clearance Certificate’ is to be issued consignment-wise by the CAPEXIL indicating details of the name and address of the exporter, address of the registered plant, IEC No. of the exporter, Plant approval number, nature of export product, quantity, invoice number and date, port of loading (name of the port) and destination; (ii) After the shipment is made, the exporter shall also provide a ‘Health Certificate’ consignment-wise to the buyer giving details of the product with HS Code, packaging, its origin, destination, vessel name, date of departure, health requirements, etc. This Health Certificate would be issued jointly by CAPEXIL and Regional Animal Quarantine Officer, Department of Animal Husbandry, Dairying and Fisheries, Ministry of Agriculture and Farmers Welfare, Government of India.]helldod] |
34/2015-20 | 13.01.2017 |
| 30 | 30021091 | Antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes | --- |
5[Free
subject NOC] [helldodold[Free]helldod] |
5[1. Any human biological
materials/samples/products which are related to activities covered under
the provision of Drugs & Cosmetics Act 1940 & Rules thereunder are free
for export subject to No objection from CDSCO. 2. Any human biological materials/samples/products NOT covered under (1) above are free for export subject to No objection from ICMR/DHR.] [helldodold[1. Export of Whole human blood plasma and all products derived from human blood except gamma globulin and human serum albumin manufactured from human placenta and human placental blood; Raw placenta; Placental blood plasma is freely allowed subject to obtaining No Objection Certificate from DGHS 2. Exports of Gamma globulin and human serum albumin manufactured from human placenta and human placental blood is free. 3. Export of Antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes and Hemoglobin blood globulins and serum globulins is free wherein Export of the item produced from animal by-products is allowed freely but export to European Union allowed subject to the following conditions : (i) A ‘Shipment Clearance Certificate’ is to be issued consignment-wise by the CAPEXIL indicating details of the name and address of the exporter, address of the registered plant, IEC No. of the exporter, Plant approval number, nature of export product, quantity, invoice number and date, port of loading (name of the port) and destination; (ii) After the shipment is made, the exporter shall also provide a ‘Health Certificate’ consignment-wise to the buyer giving details of the product with HS Code, packaging, its origin, destination, vessel name, date of departure, health requirements, etc. This Health Certificate would be issued jointly by CAPEXIL and Regional Animal Quarantine Officer, Department of Animal Husbandry, Dairying and Fisheries, Ministry of Agriculture and Farmers Welfare, Government of India.]helldod] |
||
| 30 | 300212 | Antisera, other blood fractions and immunological
products, whether or not modified or obtained by means of
biotechnological processes -- Antisera and other blood fractions |
- | ||||
| 30 | 30021210 | For diphtheria | --- |
5[Free
subject NOC] [helldodold[Free]helldod] |
5[1. Any human biological
materials/samples/products which are related to activities covered under
the provision of Drugs & Cosmetics Act 1940 & Rules thereunder are free
for export subject to No objection from CDSCO. 2. Any human biological materials/samples/products NOT covered under (1) above are free for export subject to No objection from ICMR/DHR.] [helldodold[1. Export of Whole human blood plasma and all products derived from human blood except gamma globulin and human serum albumin manufactured from human placenta and human placental blood; Raw placenta; Placental blood plasma is freely allowed subject to obtaining No Objection Certificate from DGHS 2. Export of Samples of whole human blood plasma and all products derived from human blood; Raw placenta; Placental blood plasma in individual cases for diagnostic / therapeutic purposes is free subject to recommendation of the doctor.]helldod] |
||
| 30 | 30021220 | For tetanus | --- |
5[Free
subject NOC] [helldodold[Free]helldod] |
5[1. Any human biological
materials/samples/products which are related to activities covered under
the provision of Drugs & Cosmetics Act 1940 & Rules thereunder are free
for export subject to No objection from CDSCO. 2. Any human biological materials/samples/products NOT covered under (1) above are free for export subject to No objection from ICMR/DHR.] [helldodold[1. Export of Whole human blood plasma and all products derived from human blood except gamma globulin and human serum albumin manufactured from human placenta and human placental blood; Raw placenta; Placental blood plasma is freely allowed subject to obtaining No Objection Certificate from DGHS 2. Export of Samples of whole human blood plasma and all products derived from human blood; Raw placenta; Placental blood plasma in individual cases for diagnostic / therapeutic purposes is free subject to recommendation of the doctor.]helldod] |
||
| 30 | 30021230 | For rabies | --- |
5[Free
subject NOC] [helldodold[Free]helldod] |
5[1. Any human biological
materials/samples/products which are related to activities covered under
the provision of Drugs & Cosmetics Act 1940 & Rules thereunder are free
for export subject to No objection from CDSCO. 2. Any human biological materials/samples/products NOT covered under (1) above are free for export subject to No objection from ICMR/DHR.] [helldodold[Export of Whole human blood plasma and all products derived from human blood except gamma globulin and human serum albumin manufactured from human placenta and human placental blood; Raw placenta; Placental blood plasma is freely allowed subject to obtaining No Objection Certificate from DGHS]helldod] |
||
| 30 | 30021240 | For snake venom | --- |
5[Free
subject NOC] [helldodold[Free]helldod] |
5[1. Any human biological
materials/samples/products which are related to activities covered under
the provision of Drugs & Cosmetics Act 1940 & Rules thereunder are free
for export subject to No objection from CDSCO. 2. Any human biological materials/samples/products NOT covered under (1) above are free for export subject to No objection from ICMR/DHR.] [helldodold[Export of Whole human blood plasma and all products derived from human blood except gamma globulin and human serum albumin manufactured from human placenta and human placental blood; Raw placenta; Placental blood plasma is freely allowed subject to obtaining No Objection Certificate from DGHS]helldod] |
||
| 30 | 30021290 | Other | --- |
5[Free
subject NOC] [helldodold[Free]helldod] |
5[1. Any human biological
materials/samples/products which are related to activities covered under
the provision of Drugs & Cosmetics Act 1940 & Rules thereunder are free
for export subject to No objection from CDSCO. 2. Any human biological materials/samples/products NOT covered under (1) above are free for export subject to No objection from ICMR/DHR.] [helldodold[1. Export of Whole human blood plasma and all products derived from human blood except gamma globulin and human serum albumin manufactured from human placenta and human placental blood; Raw placenta; Placental blood plasma is freely allowed subject to obtaining No Objection Certificate from DGHS 2. Export of Samples of whole human blood plasma and all products derived from human blood; Raw placenta; Placental blood plasma in individual cases for diagnostic / therapeutic purposes is free subject to recommendation of the doctor.]helldod] |
||
| 30 | 30021300 | Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale | - - | Free | |||
| 30 | 30021400 | Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale | - - | Free | |||
| 30 | 30021500 | Antisera, other blood fractions and immunological
products, whether or not modified or obtained by means of
biotechnological processes -- Immunological products, put up in measured doses or in forms or packings for retail sale |
- | Free | |||
| 30 | 300241 | Vaccines, toxins, cultures of microorganisms
(excluding yeasts) and similar products: - - Vaccines for human medicine: |
|||||
| 30 | 30024111 | Single vaccines for: - - - - Cholera and typhoid |
- - - | Free | |||
| 30 | 30024112 | Single vaccines for: - - - - Hepatitis | - - - | Free | |||
| 30 | 30024113 | Single vaccines for: - - - - Tetanus | - - - | Free | |||
| 30 | 30024114 | Single vaccines for: - - - - Polio |
- - - | Free | |||
| 30 | 30024115 | Single vaccines for: - - - - Tuberculosis | - - - | Free | |||
| 30 | 30024116 | Single vaccines for: - - - - Rabies | - - - | Free | |||
| 30 | 30024117 | Single vaccines for: - - - - Japanese encephalitis |
- - - | Free | |||
| 30 | 30024118 | Single vaccines for: - - - - Whopping cough (pertussis) |
- - - | Free | |||
| 30 | 30024119 | Single vaccines for: - - - - Other | - - - | Free | |||
| 30 | 30024121 | Diphtheria, pertussis andtetanus (DPT) | - - - - | Free | |||
| 30 | 30024122 | Mixed vaccines for: - - - - Diphtheria and tetanus (DT) |
- - - | Free | |||
| 30 | 30024123 | Mixed vaccines for: - - - - Measles, mumps and rubella (MMR) |
- - - | Free | |||
| 30 | 30024124 | Mixed vaccines for: - - - - Typhoid-paratyphoid (TAB) |
- - - | Free | |||
| 30 | 30024125 | Mixed vaccines for: - - - - Typhoid-paratyphoid-cholera (TABC) |
- - - | Free | |||
| 30 | 30024129 | Mixed vaccines for: - - - - Other |
- - - | Free | |||
| 30 | 30024200 | Mixed vaccines for: - - Vaccines for veterinary medicine |
- - - | Free | |||
| 30 | 300249 | Mixed vaccines for: - - Other | |||||
| 30 | 30024910 | Mixed vaccines for: - - - Cultures of micro-organisms (excluding yeast) |
- - - | Free | |||
| 30 | 30024920 | Mixed vaccines for: - - - Toxins | - - - | Free | |||
| 30 | 30024990 | Mixed vaccines for: - - - Other | - - - | Free | |||
| 30 | 30025100 | Cell cultures, whether or not modified
- - Cell therapy products |
- | Free | |||
| 30 | 30025900 | Cell cultures, whether or not modified - - Other |
- | Free | |||
| 30 | 300290 | Other | - | ||||
| 30 | 30029010 | Human blood | --- |
5[Free
subject NOC] [helldodold[Free]helldod] |
5[1. Any human biological
materials/samples/products which are related to activities covered under
the provision of Drugs & Cosmetics Act 1940 & Rules thereunder are free
for export subject to No objection from CDSCO. 2. Any human biological materials/samples/products NOT covered under (1) above are free for export subject to No objection from ICMR/DHR.] [helldodold[1. Export of Whole human blood plasma and all products derived from human blood except gamma globulin and human serum albumin manufactured from human placenta and human placental blood; Raw placenta; Placental blood plasma is freely allowed subject to obtaining No Objection Certificate from DGHS 2. Export of Samples of whole human blood plasma and all products derived from human blood; Raw placenta; Placental blood plasma in individual cases for diagnostic / therapeutic purposes is free subject to recommendation of the doctor.]helldod] |
||
| 30 | 30029020 | Animal blood prepared for therapeutic, prophylactic or diagnostic uses | --- | Free | 1. Export of Whole human blood plasma
and all products derived from human blood except gamma globulin and
human serum albumin manufactured from human placenta and human placental
blood; Raw placenta; Placental blood plasma is freely allowed subject to
obtaining No Objection Certificate from
DGHS 2. Export of Samples of whole human blood plasma and all products derived from human blood; Raw placenta; Placental blood plasma in individual cases for diagnostic / therapeutic purposes is free subject to recommendation of the doctor. |
||
| 30 | 30029090 | Other | --- | Free | |||
| 30 | 3003 | Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale | |||||
| 30 | 30031000 | Containing penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivatives | - | Free | |||
| 30 | 30032000 | Other, containing antibiotics | - | Free | |||
| 30 | 30033100 | Other, containing hormones or other products of
heading 29.37 : -- Containing insulin |
- | Free | |||
| 30 | 30033900 | Other, containing hormones or other products of
heading 29.37 : -- Other |
- | Free | |||
| 30 | 30034100 | Other, containing alkaloids or derivatives thereof : -- Containing ephedrine or its salts |
- | Free | Subject to Policy Condition 2 of the Chapter | ||
| 30 | 30034200 | Other, containing alkaloids or derivatives thereof : -- Containing pseudoephedrine (INN) or its salts |
- | Free | Subject to Policy Condition 2 of the Chapter | ||
| 30 | 30034300 | Other, containing alkaloids or derivatives thereof : -- Containing norephedrine or its salts |
- | Free | Subject to Policy Condition 2 of the Chapter | ||
| 30 | 30034900 | Other, containing alkaloids or derivatives thereof : -- Other |
- | Free | Subject to Policy Condition 2 of the Chapter | ||
| 30 | 30036000 | Other, containing antimalarial active principles described in Subheading Note 2 to this Chapter | - | Free | |||
| 30 | 300390 | Other | - | ||||
| 30 | 30039011 | Ayurvedic, Unani, siddha, Homoeopathic or bio-chemic systems medicaments: ---- Of Ayurvedic System | --- | Free | Subject to Policy Condition 2 of the Chapter | ||
| 30 | 30039012 | Ayurvedic, Unani, siddha, Homoeopathic or bio-chemic
systems medicaments: ---- Of Unani systems |
--- | Free | Subject to Policy Condition 2 of the Chapter | ||
| 30 | 30039013 | Ayurvedic, Unani, siddha, Homoeopathic or bio-chemic
systems medicaments: ---- Of Siddha system |
--- | Free | Subject to Policy Condition 2 of the Chapter | ||
| 30 | 30039014 | Ayurvedic, Unani, siddha, Homoeopathic or bio-chemic systems medicaments: ---- Of Homoeopathic System | --- | Free | Subject to Policy Condition 2 of the Chapter | ||
| 30 | 30039015 | Ayurvedic, Unani, siddha, Homoeopathic or bio-chemic
systems medicaments: ---- Of Bio-chemic system |
--- | Free | Subject to Policy Condition 2 of the Chapter | ||
| 30 | 30039021 | Menthol crystals and Milk of Magnesia: ---- Menthol crystals |
--- | Free | |||
| 30 | 30039022 | Menthol crystals and Milk of Magnesia: ---- Milk of Magnesia |
--- | Free | |||
| 30 | 30039031 | Bovine Albumin and drugs of animal origin,
Merbromine National Formulary XII (Mercurochrome), Calcium Sennoside,
Anaesthetic agents used in human or veterinary medicine or surgery,
Aluminium hydroxide gel: ---- Bovine Albumin and drugs of animal origin |
--- | Free | |||
| 30 | 30039032 | Bovine Albumin and drugs of animal origin,
Merbromine National Formulary XII (Mercurochrome), Calcium Sennoside,
Anaesthetic agents used in human or veterinary medicine or surgery,
Aluminium hydroxide gel: ---- Merbromine National Formulary XII (mercurochrome) |
--- | Free | |||
| 30 | 30039033 | Bovine Albumin and drugs of animal origin,
Merbromine National Formulary XII (Mercurochrome), Calcium Sennoside,
Anaesthetic agents used in human or veterinary medicine or surgery,
Aluminium hydroxide gel: ---- Calcium Sennoside |
--- | Free | |||
| 30 | 30039034 | Bovine Albumin and drugs of animal origin,
Merbromine National Formulary XII (Mercurochrome), Calcium Sennoside,
Anaesthetic agents used in human or veterinary medicine or surgery,
Aluminium hydroxide gel: ---- Anaesthetic agents used in human or veterinary medicine or surgery |
--- | Free | |||
| 30 | 30039035 | Bovine Albumin and drugs of animal origin,
Merbromine National Formulary XII (Mercurochrome), Calcium Sennoside,
Anaesthetic agents used in human or veterinary medicine or surgery,
Aluminium hydroxide gel: ---- Aluminium hydroxide gel |
--- | Free | |||
| 30 | 30039036 | Bovine Albumin and drugs of animal origin, Merbromine National Formulary XII (Mercurochrome), Calcium Sennoside, Anaesthetic agents used in human or veterinary medicine or surgery, Aluminium hydroxide gel: ---- Ketamine | --- | Free | Free, However export of Ketamine is allowed subject to obtaining No Objection Certificate from Narcotics Commissioner | ||
| 30 | 30039090 | Bovine Albumin and drugs of animal origin,
Merbromine National Formulary XII (Mercurochrome), Calcium Sennoside,
Anaesthetic agents used in human or veterinary medicine or surgery,
Aluminium hydroxide gel: ---- Other |
--- | Free | |||
| 30 | 3004 | Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. | Free | ||||
| 30 | 300410 | containing Penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivatives | - | Free | |||
| 30 | 30041010 | Penicillins | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30041020 | Ampicillin | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30041030 | Amoxycillin | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30041040 | Becampicillin | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30041050 | Cloxacillin | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30041060 | Ampicillin and Cloxacillin combinations | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30041070 | Streptomycin | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30041090 | Other | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 300420 | Other, containing antibiotics | - | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30042011 | Cephalosporins and their derivatives: ---- Cefazolin | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30042012 | Cephalosporins and their derivatives: ---- Cephalexin | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30042013 | Cephalosporins and their derivatives: ---- Ciprofloxacin | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30042014 | Cephalosporins and their derivatives: ---- Cefoxitin | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30042019 | Cephalosporins and their derivatives: ---- Other | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30042020 | Cephalosporins and their derivatives: ---- Sulfonamides and Cotrimoxazole |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30042031 | Fluoroquinolones: ---- Norfloxacin | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30042032 | Fluoroquinolones: ---- Nalidixic acid |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30042033 | Fluoroquinolones: ---- Ciprofloxacin | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30042034 | Fluoroquinolones: ---- Ofloxacin | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30042039 | Fluoroquinolones: ---- Other |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30042041 | Tetracyclines: ---- Chlortetracycline |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30042042 | Tetracyclines: ---- Oxytetracycline |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30042049 | Tetracyclines: ---- Other | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30042050 | Tetracyclines: ---- Chloramphenicol |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30042061 | Macrolide: ---- Erythromycin |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30042062 | Macrolide: ---- Roxithromycin |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30042063 | Macrolide: ---- Clarithromycin |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30042064 | Macrolide: ---- Azithromycin |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30042069 | Macrolide: ---- Other | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30042070 | Macrolide: ---- Cefadroxil |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30042091 | Other: ---- Isoniazid |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30042092 | Other: ---- Rifampicin |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30042093 | Other: ---- Pyrazinamide |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30042094 | Other: ---- Ethambutol |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30042095 | Other: ---- Clindamycin |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30042096 | Other: ---- Vancomycin |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30042097 | Other: ---- Polymyxin B and Colistin |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30042099 | Other: ---- Hormones or other products |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 300431 | Other, containing hormones or other products of
heading 29.37 : -- Containing insulin |
- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30043110 | Insulin injection | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30043190 | Other | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30043200 | Other, containing hormones or other products of heading 29.37 : -- Containing corticosteroid hormones, their derivatives or structural analogues | - | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 300439 | Other, containing hormones or other products of
heading 29.37 : -- Other |
- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30043911 | Pituitary hormones; Prednisolone; Dexamethasone;
Danazol; Other progestogen and oestogen group hormones: ---- Pituitary hormones |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30043912 | Pituitary hormones; Prednisolone; Dexamethasone;
Danazol; Other progestogen and oestogen group hormones: ---- Prednisolone |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30043913 | Pituitary hormones; Prednisolone; Dexamethasone;
Danazol; Other progestogen and oestogen group hormones: ---- Dexamethasone |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30043914 | Pituitary hormones; Prednisolone; Dexamethasone;
Danazol; Other progestogen and oestogen group hormones: ---- Danazol |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30043919 | Pituitary hormones; Prednisolone; Dexamethasone;
Danazol; Other progestogen and oestogen group hormones: ---- Other progestogen and oestogen group hormones |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30043921 | Gonadotrophins and luteinising hormone: ---- Gonadotrophins |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30043922 | Gonadotrophins and luteinising hormone: ---- Luteinising hormone |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30043990 | Gonadotrophins and luteinising hormone: ---- Other |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30044100 | Other, containing alkaloids or derivatives thereof : -- Containing ephedrine or its salts |
- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30044200 | Other, containing alkaloids or derivatives thereof : -- Containing pseudoephedrine (INN) or its salts |
- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30044300 | Other, containing alkaloids or derivatives thereof : -- Containing norephedrine or its salts |
- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 300449 | Other, containing alkaloids or derivatives thereof : -- Other |
- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30044910 | Atropine and salts thereof | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30044920 | Caffeine and salts thereof | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30044930 | Codeine and derivatives, with or without ephedrine hydrochloride | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30044940 | Ergot preparations, ergotamine and salts thereof | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30044950 | Papavarine hydrochloride | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30044960 | Bromohexin and salbutamol | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30044970 | Theophylline and salts thereof | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30044990 | Other | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 300450 | Other, containing vitamins or other products of heading 29.36 | - | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30045010 | Heamatinics and Erythropoyetin preperations | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30045020 | Preperations of minerals and their supplements | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30045031 | Preparations of vitamins: ---- Of Vitamin A | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30045032 | Preparations of vitamins: ---- Of Vitamin B1 and B2 and their salts thereof |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30045033 | Preparations of vitamins: ---- Of Vitamin B9 | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30045034 | Preparations of vitamins: ---- Of Vitamin B12 | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30045035 | Preparations of vitamins: ---- Of Vitamin C | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30045036 | Preparations of vitamins: ---- Of Vitamin D | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30045037 | Preparations of vitamins: ---- Of Vitamin E | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30045039 | Preparations of vitamins: ---- Other | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30045090 | Other | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30046000 | Other, containing antimalarial active principles described in Subheading Note 2 to this Chapter | - | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 300490 | Other | - | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049011 | Ayurvedic, Unani, Homoeopathic, Siddha or Bio-chemic
systems medicaments, put up for retail sale: ---- Of Ayurvedic System |
--- | Free | Subject to Policy Condition 1&2 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049012 | Ayurvedic, Unani, Homoeopathic, Siddha or Bio-chemic
systems medicaments, put up for retail sale: ---- Of Unani systems |
--- | Free | Subject to Policy Condition 1&2 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049013 | Ayurvedic, Unani, Homoeopathic, Siddha or Bio-chemic
systems medicaments, put up for retail sale: ---- Of Siddha system |
--- | Free | Subject to Policy Condition 1&2 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049014 | Ayurvedic, Unani, Homoeopathic, Siddha or Bio-chemic
systems medicaments, put up for retail sale: ---- Of Homoeopathic System |
--- | Free | Subject to Policy Condition 1&2 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049015 | Ayurvedic, Unani, Homoeopathic, Siddha or Bio-chemic
systems medicaments, put up for retail sale: ---- Of Bio-chemic system |
--- | Free | Subject to Policy Condition 1&2 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049021 | Anthelmintics drugs; Antiamoebic and other
Antiprotozal drugs; Antifungal drugs: ---- Anthelmintics and preparations thereof |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049022 | Anthelmintics drugs; Antiamoebic and other
Antiprotozal drugs; Antifungal drugs: ---- Metronidazole |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049023 | Anthelmintics drugs; Antiamoebic and other
Antiprotozal drugs; Antifungal drugs: ---- Tinidazole |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049024 | Anthelmintics drugs; Antiamoebic and other
Antiprotozal drugs; Antifungal drugs: ---- Secnidazole |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049025 | Anthelmintics drugs; Antiamoebic and other
Antiprotozal drugs; Antifungal drugs: ---- Diloxamide Furoate |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049026 | Anthelmintics drugs; Antiamoebic and other
Antiprotozal drugs; Antifungal drugs: ---- Sodium Stibogluconate |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049027 | Anthelmintics drugs; Antiamoebic and other
Antiprotozal drugs; Antifungal drugs: ---- Pentamidine |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049029 | Anthelmintics drugs; Antiamoebic and other
Antiprotozal drugs; Antifungal drugs: ---- Other |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049031 | Antihistaminics drugs; Antacids preparations;
Antiulcer drugs; Antiemitics and other Gastrointestinal drugs: ---- Promethazine, Chlorphenimiramine, Astemizole and Ceteirizine |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049032 | Antihistaminics drugs; Antacids preparations;
Antiulcer drugs; Antiemitics and other Gastrointestinal drugs: ---- Sodium bicarbonate, Magnesium hydroxide (Milk of Magnesia), Magnesium carbonate, Magnesium trisilicate, Aluminium hydroxide gel, Magaldarate and combinations thereof |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049033 | Antihistaminics drugs; Antacids preparations;
Antiulcer drugs; Antiemitics and other Gastrointestinal drugs: ---- Cimetidine, Rantidine, Nizatidine and Roxatidine |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049034 | Antihistaminics drugs; Antacids preparations;
Antiulcer drugs; Antiemitics and other
Gastrointestinal drugs: ---- Omeprazole and Lansoprazole |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049035 | Antihistaminics drugs; Antacids preparations;
Antiulcer drugs; Antiemitics and other
Gastrointestinal drugs: ---- Dicyclomine, Metoclopramide and Dexamethasone and Ondansetron |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049036 | Antihistaminics drugs; Antacids preparations;
Antiulcer drugs; Antiemitics and other Gastrointestinal drugs: ---- Chenodiol and Ursodiol |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049039 | Antihistaminics drugs; Antacids preparations;
Antiulcer drugs; Antiemitics and other Gastrointestinal drugs: ---- Other |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049041 | Anticancer drugs: ---- Cyclophosphamide |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049042 | Anticancer drugs: ---- Methotrexate, 5-fluorouracil(5FU) and Ftorafur |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049043 | Anticancer drugs: ---- Bincristine and Vinblastine |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049044 | Anticancer drugs: ---- Paclitaxel and Docetaxel |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049045 | Anticancer drugs: ---- Etoposide | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049046 | Anticancer drugs: ---- Actinomycin D-Dactinomycin and Doxorubicin |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049047 | Anticancer drugs: ---- L-Asparaginase, Cisplatin and Carboplatin |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049048 | Anticancer drugs: ---- Tamoxifen | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049049 | Anticancer drugs: ---- Other | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049051 | Antitubercular drugs; Antileprotic drugs;
Antimalarial drugs: ---- Isoniazid |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049052 | Antitubercular drugs; Antileprotic drugs;
Antimalarial drugs: ---- Rifampicin |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049053 | Antitubercular drugs; Antileprotic drugs;
Antimalarial drugs: ---- Pyrazimamide and Ethambutol |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049054 | Antitubercular drugs; Antileprotic drugs;
Antimalarial drugs: ---- Streptomycin |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049055 | Antitubercular drugs; Antileprotic drugs;
Antimalarial drugs: ---- Dapsone(DDS), Acedapsone
(DADDS), Solopsone and Clofazimine |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049056 | Antitubercular drugs; Antileprotic drugs;
Antimalarial drugs: ---- Chloroquine, Amodiaquine,
Mefloquine, Quinine, Chloroguamamide, Pyrimethamine |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049057 | Antitubercular drugs; Antileprotic drugs; Antimalarial drugs: ---- Other Antitubercular drugs | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049058 | Antitubercular drugs; Antileprotic drugs; Antimalarial drugs: ---- Other Antileprotic drugs | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049059 | Antitubercular drugs; Antileprotic drugs; Antimalarial drugs: ---- Other Antimalarial drugs | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049061 | Nonsteroidal antiinflammatory, analgesics and antipyratic drugs: ---- Analgin with or without other compounds such as paracetamol | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049062 | Nonsteroidal antiinflammatory, analgesics and antipyratic drugs: ---- Acetyl salicylic acid (Aspirin) and formulations thereof | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049063 | Nonsteroidal antiinflammatory, analgesics and antipyratic drugs: ---- Ibuprofen with or without paracetamol or other compunds | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049064 | Nonsteroidal antiinflammatory, analgesics and antipyratic drugs: ---- Oxyphen butazone, Phenyl butazone and formulations thereof | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049065 | Nonsteroidal antiinflammatory, analgesics and
antipyratic drugs: ---- Indomethacin |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049066 | Nonsteroidal antiinflammatory, analgesics and antipyratic drugs: ---- Mephenamic acid, dactofenac sodium, Piroxicam, Tenoxicam and Meloxicam | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049067 | Nonsteroidal antiinflammatory, analgesics and
antipyratic drugs: ---- Ketorolac, Nimesulide, Mabumetone and Nefopam |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049069 | Nonsteroidal antiinflammatory, analgesics and
antipyratic drugs: ---- Other |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049071 | Antihepertensive drugs: ---- Captopril, Enalapril, Lisimopril, Perimdopril and Ramipril |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049072 | Antihepertensive drugs: ---- Verapamil, Nifedipine, Amlodipine and Lacidipine |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049073 | Antihepertensive drugs: ---- Losartam | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049074 | Antihepertensive drugs: ---- Propranolol, Metoprolol, Atenolol and Labetalol |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049075 | Antihepertensive drugs: ---- Prazosin, Terazosin, Phentolamine and Phenoxybenzamime |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049076 | Antihepertensive drugs: ---- Clonidine, Methyldopa |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049077 | Antihepertensive drugs: ---- Hydralazine, Minoxidil and Diazoxide |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049079 | Antihepertensive drugs: ---- Other | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049081 | Antiepiliptic drugs; Sulfa drugs not elsewhere specified or included, Preparations of enzymes; veterinary medicinal preparations, not for human use, not elsewhere specified or included; Oral rehydration salts; Antibacterial formulations not elsewhere specified or included, Sedatives and Tranquilizers: ---- Phenobarbitone, Memphobarbitone, Primidone, Phenytoin, Carbamazepine, Ethosuximide, Valporic acid (Sodium valporate), Diazepam, Lamotrigine, Gabapentin, Bigabatrin, Phenacemide, Trimethadione and Acetazolamide | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049082 | Antiepiliptic drugs; Sulfa drugs not elsewhere
specified or included, Preparations of enzymes; veterinary medicinal
preparations, not for human use, not elsewhere specified or included;
Oral rehydration salts; Antibacterial formulations not elsewhere
specified or included, Sedatives and Tranquilizers: ---- Other Antiepileptic drugs |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049083 | Antiepiliptic drugs; Sulfa drugs not elsewhere
specified or included, Preparations of enzymes; veterinary medicinal
preparations, not for human use, not elsewhere specified or included;
Oral rehydration salts; Antibacterial formulations not elsewhere
specified or included, Sedatives and Tranquilizers: ---- Sulpha drugs not elsewhere specified or included |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049084 | Antiepiliptic drugs; Sulfa drugs not elsewhere
specified or included, Preparations of enzymes; veterinary medicinal
preparations, not for human use, not elsewhere specified or included;
Oral rehydration salts; Antibacterial formulations not elsewhere
specified or included, Sedatives and Tranquilizers: ---- Preparations of Enzymes |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049085 | Antiepiliptic drugs; Sulfa drugs not elsewhere
specified or included, Preparations of enzymes; veterinary medicinal
preparations, not for human use, not elsewhere specified or included;
Oral rehydration salts; Antibacterial formulations not elsewhere
specified or included, Sedatives and Tranquilizers: ---- Veterinary medicinal preparations, not for human use, not elsewhere specified or included |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049086 | Antiepiliptic drugs; Sulfa drugs not elsewhere
specified or included, Preparations of enzymes; veterinary medicinal
preparations, not for human use, not elsewhere specified or included;
Oral rehydration salts; Antibacterial formulations not elsewhere
specified or included, Sedatives and Tranquilizers: ---- Oral rehydration salts |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049087 | Antiepiliptic drugs; Sulfa drugs not elsewhere
specified or included, Preparations of enzymes; veterinary medicinal
preparations, not for human use, not elsewhere specified or included;
Oral rehydration salts; Antibacterial formulations not elsewhere
specified or included, Sedatives and Tranquilizers: ---- Antibacterial formulations, not elsewhere specified or included |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049088 | Antiepiliptic drugs; Sulfa drugs not elsewhere
specified or included, Preparations of enzymes; veterinary medicinal
preparations, not for human use, not elsewhere specified or included;
Oral rehydration salts; Antibacterial formulations not elsewhere
specified or included, Sedatives and Tranquilizers: ---- Sedatives |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049089 | Antiepiliptic drugs; Sulfa drugs not elsewhere specified or included, Preparations of enzymes; veterinary medicinal preparations, not for human use, not elsewhere specified or included; Oral rehydration salts; Antibacterial formulations not elsewhere specified or included, Sedatives and Tranquilizers: ---- Tranquilizers | --- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049091 | Other: ---- Salbutamol, Terbutaline, Ephedrine, Salmeterol and Methyl xanthimes |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049092 | Other: ---- Plasma expanders |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049093 | Other: ---- Chloropheniramine Maleate, with or without other compounds (excluding steriods and alkaloids) |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049094 | Other: ---- Theophylline, Aminophylline and other Broncho dilators |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049095 | Other: ---- Carcino-chemotherapeutic drugs not elsewhere specified or included |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 30049096 | Other: ---- Ketamine |
--- | Free | Subject to Policy Condition 1 of the Chapter
Furthermore, export of Ketamine is allowed subject to obtaining No Objection Certificate from Narcotics Commissioner |
06/2023 | 22.05.2023 |
| 30 | 30049099 | Other: ---- Other |
--- | Free | Subject to Policy Condition 1 of the Chapter | 06/2023 | 22.05.2023 |
| 30 | 3005 | Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes. | |||||
| 30 | 300510 | Adhesive dressings and other articles having an adhesive layer | - | ||||
| 30 | 30051010 | Adhesive guaze | --- | Free | |||
| 30 | 30051020 | Adhesive tape | --- | Free | |||
| 30 | 30051090 | Other | --- | Free | |||
| 30 | 300590 | Other | - | Free | |||
| 30 | 30059010 | Cotton wool, medicated | --- | Free | |||
| 30 | 30059020 | Poultice of Kaolin | --- | Free | 39/2015-2020 | 14.10.2021 | |
| 30 | 30059030 | Lint, medicated | --- | Free | 39/2015-2020 | 14.10.2021 | |
| 30 | 30059040 | Bandages | --- | Free | 39/2015-2020 | 14.10.2021 | |
| 30 | 30059050 | Burn therapy dressing soaked in protective gel | --- | Free | 39/2015-2020 | 14.10.2021 | |
| 30 | 30059060 | Micro pores surgical tapes | --- | Free | 39/2015-2020 | 14.10.2021 | |
| 30 | 30059070 | Corn removers and callous removers | --- | Free | 39/2015-2020 | 14.10.2021 | |
| 30 | 30059090 | Other | --- | Free | 39/2015-2020 | 14.10.2021 | |
| 30 | 3006 | Pharmaceutical goods specified in Note 4 to this Chapter. | 39/2015-2020 | 14.10.2021 | |||
| 30 | 300610 | Sterile surgical catgut, similar sterile suture materials (including sterile absorbable surgical or dental yarns) and sterile tissue adhesives for surgical wound closure; sterile laminaria and sterile laminaria tents; sterile absorbable surgical or dental haemostatics; sterile surgical or dental adhesion barriers, whether or not absorbable | - | Free | 39/2015-2020 | 14.10.2021 | |
| 30 | 30061010 | Sterile surgical catgut, similar sterile suture materials (including sterile absorbable surgical or dental yarns) and sterile tissue adhesives for surgical wound closure | --- | Free | |||
| 30 | 30061020 | sterile laminaria and sterile laminaria tents; sterile absorbable surgical or dental haemostatics; sterile surgical or dental adhesion barriers, whether or not absorbable | --- | Free | |||
| 30 | 30063000 | Opacifying preparations for X-ray examinations; diagnostic reagents designed to be administered to the patient | - | Free | |||
| 30 | 30064000 | Dental cements and other dental
fillings; bone reconstruction cements |
- | Free | |||
| 30 | 30065000 | First-aid boxes and kits | - | Free | |||
| 30 | 300660 | Chemical contraceptive preparations based on hormones, on other products of heading 29.37 or on spermicides | - | ||||
| 30 | 30066010 | Based on hormones | --- | Free | |||
| 30 | 30066020 | Based on other products of heading 2937 | --- | Free | |||
| 30 | 30066030 | Based on spermicides | --- | Free | |||
| 30 | 30067000 | Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments | - | Free | |||
| 30 | 30069100 | Other : -- Appliances identifiable for ostomy use |
- | Free | |||
| 30 | 30069300 | Cell cultures, whether or not modified
- - Placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses |
- | Free |
]
[helldodold[CHAPTER
30
PHARMACEUTICAL
NOTE: 1
Formulations of plant portions of prohibited varieties falling in heading 3003 and heading 3004 are freely exportable subject to conditions. For details, please see chapter 12.
| S.No. | Tariff Item HS Code | Unit | Item Description | Export Policy | Policy Conditions |
| 152 | 3002 12 10 3002 12 20 3002 12 30 3002 12 40 3002 12 90 3002 10 20 3002 10 91 3002 90 10 3002 90 20 |
Kg |
Whole human blood plasma and all products derived from human blood except gamma globulin and human serum albumin manufactured from human placenta and human placental blood; Raw placenta; Placental blood plasma |
Free | Export allowed subject to obtaining No Objection Certificate from DGHS |
| 153 | 3002 10 20 | Kg |
Gamma globulin and human serum albumin manufactured from human placenta and human placental blood |
Free | |
| 154 | 3002 12 10 3002 12 20 3002 12 90 3002 10 20 3002 90 10 3002 90 20 |
Kg |
Samples of whole human blood plasma and all products derived from human blood; Raw placenta; Placental blood plasma in individual cases for diagnostic / therapeutic purposes. |
Free |
Recommendation from a Doctor |
| 155 | 3003 90 36 3004 90 96 |
Kg | Ketamine | Free |
Export allowed subject to obtaining No Objection Certificate from Narcotics Commissioner |
| 156 | 3002 10 | Kg | Antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes | Free |
Export of the item produced from animal
by-products allowed freely but export to European Union allowed subject
to the following conditions : |
| 3002 10 20 | Kg | Hemoglobin blood globulins and serum globulins | |||
| 3001 90 91 | Kg |
Heparin and its salts
|
|||
| 156 A | 30042050 | Formulations made of Chloramphenicol |
2[Free] old[1[Restricted]] old[Free]
|
||
| 156 B | 30042061 | Formulations made of Erythromycin Salts | |||
| 156 C | 30042095 | Formulations made of Clindamycin Salts | |||
| 156 D | 30043919 | Formulations made of Progesterone | |||
| 156 E | 30045032 | Formulations made of Vitamin B l | |||
| 156 F | 30045034 | Formulations made of Vitamin B12 | |||
| 156G | 30045039 | Formulations made of Vitamin B6 | |||
| 156H | 30049015 | Formulations made of Neomycin | |||
| 156I | 30049021 | Formulations made of Ornidazole | |||
| 156J | 30049022 | Formulations made of Metronidazole | |||
| 156K | 30049023 | Formulations made of Tinidazole | |||
| 156L | 30049099 | Formulations made of Acyclovir | |||
| 156M | 30049099 | Formulations made of Paracetamol | 3[Free] old[Restricted] |
Export Licencing Note of Chapter 30
“The words ‘ Heavy metals within permissible limits’ have be conspicuously displayed on the container of purely Herbal Ayurveda, Siddha and Unani medicines to be exported. Alternatively, a Certificate that ‘ Heavy metals within permissible limits ‘ issued either by an inhouse laboratory fully equipped with appropriate equipments for testing heavy metals or by any other NABL / GLP accredited laboratory or any other approved laboratory has to be produced along with other consignment papers.”]helldod]
1. Substituted Vide Notification No. 50/2015-2020 dt. 03/03/2020
2. Substituted Vide Notification No. 02/2015-2020 dt. 06/04/2020
3. Substituted Vide Notification No. 03/2015-2020 dt. 17/04/2020
4. Substituted Vide Notification No. 60/2023 dt. 13/02/2024
5. Substituted Vide Notification No. 72/2023 dt. 11/03/2024